Clinical Trial Update: A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy) [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial is evaluating a combination of calaspargase pegol-mknl, decitabine, and venetoclax in pediatric, adolescent, and young adult patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Acute Lymphoblastic Leukemia
• T-cell Lymphoblastic Lymphoma

Drugs mentioned

• Calaspargase Pegol-mknl (calaspargase pegol-mknl)
• Decitabine (Decitabine)
• Venetoclax (venetoclax)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: T-cell Acute Lymphoblastic Leukemia, T-Cell Lymphoblastic Lymphoma | Phase 2 | Status: RECRUITING